8:20 Debate: First line EGFR therapy for left sided RAS/BRAF WT metastatic colon cancer? - Yes HMP Education
8:44 Debate: Optimal salvage therapy for refractory colon cancer? - TAS102 or Regorafenib HMP Education
20:05 Impact of molecular subsets in colorectal cancer on adjuvant and advanced disease therapy HMP Education
11:58 Debate: Do molecular characteristics play a role in selecting patients for metastasectomy? - No HMP Education
8:43 Debate: Y90 Microspheres in the Management of Hepatic Metastases in GI cancers - Pro HMP Education
8:08 Debate: Y90 Microspheres in the Management of Hepatic Metastases in GI cancers - Con HMP Education
10:50 Debate: Should routine genomic profiling be performed in esophagogastric cancer? - Yes HMP Education
11:23 Debate: Optimal neoadjuvant stategy in pancreatic cancer? - Neoadjuvant Chemotherapy HMP Education
14:02 Debate: Optimal neoadjuvant stategy in pancreatic cancer? - Pre-operative Chemotherapy + Radiation HMP Education
8:43 Debate: Optimal adjuvant therapy for resected pancreatic cancer? - Gem/Nab-Paclitaxel or FOLFIRINOX HMP Education
8:28 Debate: Optimal first-line therapy in unresectable HCC? - MKI followed by immunotherapy HMP Education
10:22 Debate: Optimal adjuvant therapy for biliary cancer? - Gemcitabine or Capecitabine HMP Education
